These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 6303005)

  • 41. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 42. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
    Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
    J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines.
    Madrid-Marina V; Martinez-Valdez H; Cohen A
    Cancer Res; 1990 May; 50(10):2891-4. PubMed ID: 2110502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.
    Staal GE; Stoop JW; Zegers BJ; Siegenbeek van Heukelom LH; van der Vlist MJ; Wadman SK; Martin DW
    J Clin Invest; 1980 Jan; 65(1):103-8. PubMed ID: 6765955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of oroticaciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Potter CF; Sahota A; Cameron JS; Webster DR; Becroft DM
    Clin Exp Immunol; 1978 Oct; 34(1):42-5. PubMed ID: 108039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan.
    Kishi T; Sakura N; Ito K; Usui T
    Acta Paediatr Jpn; 1987 Feb; 29(1):152-4. PubMed ID: 3144840
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 50. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adenosine deaminase, purine nucleoside phosphorylase and ecto-5'-nucleotidase--markers of acute leukemia variants].
    Filanovskaia LI; Togo AV; Tsveĭbakh AS; Blinov MN; Alekseev NA
    Vopr Med Khim; 1987; 33(4):16-21. PubMed ID: 2821693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.
    Gelfand EW; Dosch HM; Biggar WD; Fox IH
    J Clin Invest; 1978 Apr; 61(4):1071-80. PubMed ID: 96131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
    North ME; Newton CA; Webster AD
    Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purine metabolism in adenosine deaminase deficiency.
    Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
    Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Familial immune deficit and genetic deficiency of adenosine deaminase or of nucleoside phosphorylase (author's transl)].
    Gajdos A
    Nouv Presse Med; 1978 Mar; 7(11):929-34. PubMed ID: 306093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.